Logo
    Search

    Podcast Summary

    • Understanding Schizophrenia: Positive Symptoms vs Other ImpairmentsSchizophrenia includes positive symptoms like hallucinations and delusions, and other impairments like disorganization. Positive symptoms are often the most recognized, but understanding all symptoms aids diagnosis and treatment.

      When it comes to understanding the clinical manifestations of schizophrenia, it's important to recognize the difference between positive symptoms, such as hallucinations and delusions, and other impairments. Positive symptoms, like hallucinations and delusions, are often the most well-known aspects of schizophrenia. Hallucinations involve the perception of a sensory process in the absence of an external source, while delusions are fixed false beliefs that can be bizarre or seemingly reasonable. Delusions are common in schizophrenia, with approximately 80% of individuals experiencing them. The most common hallucination is auditory, and the most common delusion is paranoid, where individuals believe that people are after them. Disorganization, another symptom, refers to disorganized speech and behavior, which can be assessed using specific subcategories. Understanding these distinctions can help mental health professionals better diagnose and treat individuals with schizophrenia.

    • Documenting Speech Patterns in Patient InterviewsAccurately documenting tangential speech, derailment, neologisms, and verbiage during patient interviews can provide valuable insights into potential mental health conditions.

      During patient interviews, it's essential to recognize and document various speech patterns accurately. Two common speech patterns discussed are tangential speech and derailment. Tangential speech occurs when a patient goes off topic but maintains some connection to the original subject. This can be frustrating during interviews but is distinguishable from derailment. Derailment refers to a sudden and illogical switch in topic without any connection. Another speech pattern discussed was neologism, the creation of new, meaningless words. Witnessing this is less common but can be identified by the lack of sensible meaning in the patient's speech. Additionally, verbiage, or the meaningless repetition of words, sentences, or associations, can be observed and documented. When conducting forensic examinations, it's challenging for patients to consistently fake these speech patterns, making them valuable indicators of potential mental health conditions. As a mental health professional, it's crucial to maintain a fresh perspective during interviews, engaging with patients and documenting their speech patterns accurately. This includes documenting exact quotes in the patient's chart to provide a clear understanding of the severity and nature of the speech patterns observed.

    • Understanding Positive and Negative Symptoms in SchizophreniaSchizophrenia symptoms include positive (hallucinations, delusions, disorganized speech/behavior) and negative (apathy, decreased motivation, cognitive impairment) types. Negative symptoms are harder to treat and impact daily life, while proper treatment can help optimize functioning.

      Schizophrenia manifests in various ways, and it's essential to understand the differences between positive and negative symptoms. Positive symptoms include hallucinations, delusions, and disorganized speech or behavior. Responding to internal stimuli (RTIS) is a type of positive symptom, which can be misunderstood if not described vividly. Negative symptoms, on the other hand, involve a diminished expression of emotions and a loss of motivation. The apathy cluster is a subcategory of negative symptoms, characterized by a decreased motivation to initiate or perform self-directed activities. Negative symptoms are harder to treat than positive ones, and medications may even induce some negative symptoms. Cognitive impairment is another category of symptoms, which includes mental processing speed issues, learning and memory problems, and reasoning difficulties. These symptoms can be present in various mental health conditions and can significantly impact daily life. Despite these challenges, proper treatment can help optimize functioning and improve outcomes for individuals with schizophrenia.

    • Considering the interplay between conditions in schizophrenia treatmentEffective schizophrenia treatment requires recognizing the impact of both the disease and medications on cognitive function, minimizing anticholinergic burden, addressing comorbid mood and anxiety disorders, and carefully evaluating individual symptoms.

      In the treatment of schizophrenia, it's crucial to consider the interplay between various conditions, as both the disease and its treatments can impact cognitive function. Antipsychotics, which are often used to manage positive symptoms, can cause cognitive impairment due to their anticholinergic properties. Therefore, minimizing the anticholinergic burden can help lessen cognitive impairment. While inpatient care focuses on bringing patients out of psychosis, outpatient care allows for more nuanced adjustments to optimize cognitive function. Furthermore, individuals with schizophrenia often experience comorbid mood and anxiety disorders, which can complicate treatment and recovery. Depression, suicide, social phobias, PTSD, and OCD are among the conditions that occur at higher rates in the schizophrenic population. Recognizing and addressing these co-occurring conditions can significantly improve treatment outcomes. Additionally, some physical manifestations, such as soft signs, may be present in individuals with schizophrenia, adding to the complexity of their care. It's essential to carefully evaluate each patient's unique situation and symptoms to effectively manage their condition.

    • Connections between Parkinson's and Schizophrenia in the Dopamine SystemMonitoring neurological disturbances like akathisia and catatonia is crucial for effective treatment of Parkinson's disease and schizophrenia. Akathisia, characterized by internal or external restlessness, can indicate adverse drug reactions. Catatonia, presenting with a range of symptoms, can be diagnosed using the Bush Francis catatonia rating scale.

      Parkinson's disease and schizophrenia share connections in the dopamine system, affecting not only motor functions but also perception and coordination. Neurological disturbances, such as akathisia, can be indicators of adverse drug reactions, and monitoring for these symptoms is crucial for effective treatment. Akathisia, a debilitating and painful condition characterized by internal or external restlessness, is important to identify and manage promptly. Catatonia, another condition related to neurological disorders, can present with a range of symptoms beyond the typical stupor or immobility, and the Bush Francis catatonia rating scale can aid in proper diagnosis and treatment. Overall, recognizing and managing these conditions requires a nuanced understanding of their symptoms and the importance of long-term patient care.

    • Recognizing Catatonia: Importance for Patient's Well-being and Legal ConsiderationsHealthcare professionals must identify catatonia in severe mental illness patients for their well-being and legal reasons. High doses of Ativan can help manage symptoms, while addressing overall health and encouraging lifestyle changes can prevent metabolic diseases.

      Catatonia, a severe mental condition characterized by motor and cognitive impairments, was once a common outcome for individuals with severe mental illnesses before the availability of medications. Today, it's crucial for healthcare professionals to recognize the signs of catatonia and consider it as a potential diagnosis, not only for the patient's well-being but also from a legal standpoint. High doses of Ativan, a benzodiazepine, have been found to be helpful in managing catatonic symptoms. Furthermore, individuals with severe mental illnesses, such as schizophrenia, have a reduced life expectancy due to metabolic conditions like diabetes, hyperlipidemia, and hypertension. Therefore, it's essential to address the patient's overall health, including their mental and physical well-being, and encourage lifestyle changes, such as exercise, to mitigate the risk of metabolic diseases.

    • Going Beyond Medication for Schizophrenia ManagementEffective schizophrenia management includes addressing health issues, self-advocacy, and recognizing precursor symptoms for timely treatment. People experiencing homelessness may require special attention due to unique challenges. A holistic approach is essential for optimal recovery.

      Effective management of schizophrenia involves more than just medication. While medications can help control symptoms, addressing other health issues and advocating for oneself can be crucial. People with schizophrenia, especially those experiencing homelessness, may describe physical symptoms in a way that's twisted by their psychosis, leading to inadequate treatment. The onset of schizophrenia is typically abrupt, with the first noticeable symptom often being a psychotic episode. However, it's essential to be aware of potential precursor signs. Timely and intensive treatment can significantly impact functional recovery. Overall, it's important to remember that treating schizophrenia goes beyond medication and requires a holistic approach.

    • Effective Treatment of SchizophreniaEarly intervention, family involvement, addressing home stressors, proper identification, medication compliance, recognizing comorbidities, and a strong therapeutic alliance can significantly improve long-term outcomes for people with schizophrenia.

      Early and intensive treatment of schizophrenia, involving the family and addressing home stressors, can significantly improve long-term outcomes for patients. Schizophrenia presents differently than commonly imagined, with negative symptoms, cognitive delays, and speech patterns often overlooked. Proper identification and treatment can prevent or reduce the number of psychotic episodes, which can cause brain damage. Building a strong therapeutic alliance and ensuring medication compliance are essential. Additionally, recognizing and addressing comorbid conditions, such as social anxiety disorder, PTSD, obsessive compulsive disorder, metabolic issues, and cardiovascular conditions, is crucial for effective and long-term treatment. Overall, with the right approach, people with schizophrenia can lead much better lives.

    • Consider medical conditions when dealing with psychotic symptomsUnderlying medical conditions, like high glucose levels, can contribute to psychotic symptoms. Explore how substances impact presentations and stay tuned for more in-depth discussions on schizophrenia.

      It's essential to consider potential medical issues when dealing with individuals presenting psychotic symptoms. In this discussion, a case was shared where a person's high glucose levels, induced by steroids for an asthma attack, contributed to their psychotic presentation. This highlights the importance of not solely focusing on psychotic symptoms but also considering underlying medical conditions. Furthermore, the speakers encouraged listeners to explore how substances like smoking and other chemicals can impact psychotic presentations. The speakers also mentioned that they would be diving deeper into this topic in their upcoming "schizophrenia series," which would include videos on YouTube and interactive discussions on Instagram. They also promised to provide links to resources and a blog post related to the episode.

    Recent Episodes from Psychiatry & Psychotherapy Podcast

    Reflective Functioning: The Key to Attachment with Dr. Howard Steele

    Reflective Functioning: The Key to Attachment with Dr. Howard Steele

    In this episode, we discuss “reflective function,” which is a precursor to the concept of mentalization. Reflective function is best understood not as synonymous with mentalization, but as a scale from -1 to 9, based off certain adult attachment interview questions that measure the person’s ability to describe their own and others’ internal states, motivations, and articulate a nuanced and unique understanding of life from 0 to 12 years old. This scale was developed by attachment researchers at the University of London, including Dr. Howard Steele and Dr. Peter Fonagy.

    Bruce Perry on the Healing Power of Human Connection and Resilience in Trauma

    Bruce Perry on the Healing Power of Human Connection and Resilience in Trauma

    In today’s episode, we talk with Dr. Bruce Perry who co-authored, The Boy Who Was Raised As A Dog, Born For Love: Why Empathy is Essential and Endangered, and What Happened to You? Conversations on Trauma, Resilience, and Healing (2021). We are also joined by Megan White Zappitelli, M.D., a child and adolescent psychiatrist, and Maddison Hussey, M.D., a child and adolescent fellow. 

    Early Psychosis: Detection and Treatment

    Early Psychosis: Detection and Treatment

    In this episode, we are joined by a panel of experts to discuss treatment of psychosis. Experiences of psychosis are common. When these experiences lead to interference in achieving life goals and/or distress, individuals can benefit from seeking evidenced-based care. The earlier individuals experiencing psychosis come to treatment, the better the outcomes. We are all allies in connecting these young people to care and services. Recovery is possible—people living with psychosis experiences can lead full, meaningful, and fulfilling lives. 

    Q&A with Dr. Michael Cummings

    Q&A with Dr. Michael Cummings

    In this episode, we welcome back fan favorite Dr. Michael Cummings and ask questions sent in by listeners. Topics include Schizophrenia, Social Media Trends, and the SSRI controversy. We are thrilled to dedicate an episode that allows individuals to ask pointed questions and glean from Dr. Cummings' expertise. 

    What People Want From Therapy with Linda Michaels

    What People Want From Therapy with Linda Michaels

    Therapies of depth, insight, and relationship have been missing from, if not pushed out of, the public conversation on mental health treatment. After decades of attack from multiple fronts, these therapies are misunderstood, undervalued, and overlooked by the general public. In order to address this challenge and change this trajectory, we must start by listening to the public and understand their needs, values, and preferences about therapy. Dr. Linda Michaels and colleagues conducted an extensive research project, leveraging qualitative and quantitative tools and techniques widely used in the corporate world, focused on “listening” to the public and understanding what people want and need from therapy. 

    Linda Michaels, PsyD, MBA, is a clinical psychologist in private practice in Chicago. She is also chair and co-founder of the Psychotherapy Action Network (PsiAN), a non-profit that advocates for quality therapy. 

    Link to blog here.

    5 Factors and Domains of Psychiatric Care

    5 Factors and Domains of Psychiatric Care

    In this Episode, Dr. David Puder, Dr. Adam Borecky, and Joanie Burns discuss the 5-factor approach to holistic, patient-centered psychiatric care. This approach takes into account that each individual who seeks care is unique in their physiological and psychological make-up and that multiple factors influence both physical and mental health (for better or worse). 

    The 5-factor approach to treatment is based on the importance of sensorium and its pivotal role in regulating thoughts, feelings, and overall mental health. Sensorium is a lens to understand how we focus on various things. Sensorium is total brain function, which fluctuates throughout the day and depends on a number of factors, including sleep, stress levels, and more.

    Mentalization Based Therapy (MBT), with Dr. Anthony W. Bateman, MA, FRCPSYCH and Dr. Peter Fonagy, Ph.D., FBA

    Mentalization Based Therapy (MBT), with Dr. Anthony W. Bateman, MA, FRCPSYCH and Dr. Peter Fonagy, Ph.D., FBA

    In this episode, we are joined by Dr. Anthony W. Bateman and Dr. Peter Fonagy to discuss their expertise on Mentalization. 

    Mentalization refers to the capacity to reflect upon and understand one's own state of mind and the states of mind of others.  This involves recognizing and making sense of one's own and others’ emotions, beliefs, needs and desires.  People use this tool consciously and unconsciously to make sense of others and themselves. Often done automatically, a person may form beliefs about the people they interact with, making assumptions about their mental states. These beliefs tend to have a strong influence on the mental state of the person, whether or not they are correct.

     

    Beginning the Treatment with Jonathan Shedler, PhD

    Beginning the Treatment with Jonathan Shedler, PhD

    Dr. Jonathan Shedler is well known for his work on the efficacy of psychodynamic therapy. He has highlighted the importance of the initial phase of therapy in establishing a foundation for successful treatment. Dr. Shedler strongly believes the consultation phase is crucial to developing a working alliance between client and therapist and building a treatment frame and structure. Without this foundation, there is no mutual understanding about the goal or the purpose of treatment, and psychotherapy should not move forward. Join us in this episode as Dr. Shelder discusses how to create a firm starting foundation in clinical practice.

    Adverse Childhood Experiences Part 2: Measurement, Impact on Future Mental Health, Dissociation, and Timing of Trauma

    Adverse Childhood Experiences Part 2: Measurement, Impact on Future Mental Health, Dissociation, and Timing of Trauma

    In this week’s episode of the podcast, we will continue our discussion regarding adverse childhood experiences (ACEs) and their influence on the development of future mental health disorders. The greatest predictive factor of the relationship between ACEs and future mental health disorders has to do with the severity, duration, and number of traumatic events. We’ll explore the Childhood Trauma Questionnaire and the data of how ACEs increase the risk of certain personality disorders and psychiatric conditions.

    Link to blog: 

    https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/episode-204-adverse-childhood-experiences-part-2-measurement-impact-on-future-mental-health-dissociation-and-timing-of-trauma

    Related Episodes

    The History and Use of Antipsychotics

    The History and Use of Antipsychotics

    In the latest podcast, Dr. Cummings and I talked about antipsychotics, the particular branch of psychopharmacology that deals with medicines that treat psychotic experiences and other mental disorders, such as:

    Schizophrenia

    Severe depression

    Severe anxiety

    Bipolar disorder

    Psychosis exhibiting hallucinations and delusions

    For blog and detailed notes and citations from the episode: here

    Join David on Instagram: dr.davidpuder

    Twitter: @DavidPuder

    Schizophrenia Differential Diagnosis & DSM5

    Schizophrenia Differential Diagnosis & DSM5

    Schizophrenia is a diagnosis of exclusion. Doctors and therapists need to be able to rule everything else out before they can land on schizophrenia as an official diagnosis. There are specific symptoms are known as “first-rank symptoms,” which we will cover later in the article, that will help with diagnosing patients (Schneider, 1959). Eighty-five percent of people with schizophrenia endorse these symptoms, but be wary of jumping to conclusions because they are not specific to schizophrenia and, in some studies, are also endorsed by bipolar manic patients (Andreasen, 1991).

    DSM5 (Diagnostic and Statistical Manual of Mental Disorders 5th ed.)

    Schizophrenia is a clinical diagnosis made through observation of the patient and the patient’s history.

    There must be 2 or more of the characteristic symptoms below (Criterion A) with at least one symptom being items 1, 2 or 3. These symptoms must be present for a significant portion of time during a 1 month period (or less, if successfully treated).

    The patient must have continuous, persistent signs of disturbance for at least 6 months, which includes the 1 month period of symptoms (or less, if successfully treated) and may include prodromal or residual periods.

    For a significant portion of the time since the onset of the disturbance, one or more major areas of functioning such as work, interpersonal relations, or self-care are markedly below the level achieved prior to the onset.

    If the onset is in childhood or adolescence, there is failure to achieve expected level of interpersonal, academic, or occupational achievement.

    Criterion A:

    A. Positive symptoms (presence of abnormal behavior)

    1. Delusions

    2. Hallucinations

    3. Disorganized speech (eg, frequent derailment or incoherence)

    4. Grossly disorganized or catatonic behavior

    B. Negative symptoms (absence or disruption of normal behavior)

    5. Negative symptoms include affective flattening, alogia, avolition, anhedonia, asociality.

    Link to full episode: notes

    Resource Library: here

    Link to sign up for CME go: here

    Member Login to do CME activity go: here

    Instagram:dr.davidpuder

    Twitter:@DavidPuder

    Facebook: DrDavidPuder

    Youtube channel

    Schizophrenia Treatment: Clozapine, LAIs, Technology and Equity with John Kane, MD and Lauren Hanna, MD

    Schizophrenia Treatment: Clozapine, LAIs, Technology and Equity with John Kane, MD and Lauren Hanna, MD

    John M. Kane, MD. is Professor of Psychiatry and Molecular Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

    Dr. Kane earned his medical degree from New York University in New York, New York, and completed his internship and residency in Psychiatry at The Zucker Hillside Hospital. He is a diplomate of the American Board of Psychiatry and Neurology.

    Dr. Kane is the recipient of many awards, including the Lieber Prize, The APA’s Kempf Award and Foundations Prize, the New York State Office of Mental Health Lifetime Achievement Award, and the Dean Award from the American College of Psychiatrists. He has served as President of the American Society of Clinical Psychopharmacology, the Psychiatry Research Society and the Schizophrenia International Research Society.

    Dr. Kane has been the principal investigator on 23 NIH grants focusing on schizophrenia, psychobiology and treatment, recovery, and improving the quality and cost of care. He is the author of over 900 peer-reviewed papers and serves on the editorial boards of numerous journals. 

    Valproic Acid: History, Mechanism, Treatment in Bipolar, Schizophrenia, Aggression and Side Effects with Dr. Cummings

    Valproic Acid: History, Mechanism, Treatment in Bipolar, Schizophrenia, Aggression and Side Effects with Dr. Cummings

    In this episode, David Puder, M.D. and Michael Cummings, M.D. discuss the history, uses, and side effects of Valproic Acid which is a mood stabilizer for various conditions including: Bipolar Disorder, Schizophrenia, and Borderline Personality Disorder. 

    Link to Blog:

    Schizophrenia with Dr. Cummings: Controversies, Brain Science, Crime, History, Exercise, Successful Treatment

    Schizophrenia with Dr. Cummings: Controversies, Brain Science, Crime, History, Exercise, Successful Treatment

    In this episode, Dr. Puder addresses the fascinating realm of schizophrenia with Dr. Cummings, a previous guest in the show. Dr. Cummings is a psychiatrist with a wealth of experience from working at Patton State Hospital in California, one of the biggest forensic hospitals in the world.

    -Defining Schizophrenia

    -Living with Schizophrenia and Perception of Reality

    -Are Negative Symptoms in Schizophrenia Precipitated by Medications?

    -Emil Kraepelin, and the Early Studies on Schizophrenia

    -The Pathology, Biology, and Genetics of Schizophrenia

    -Cannabis Use and Risk For Schizophrenia

    -The Loss of Brain in Schizophrenia

    -Counter-arguments Against Robert Whitaker’s “Anatomy of an Epidemic”        

    -Schizophrenia Prevention in High Risk Population

    -Australian Study on Children of Schizophrenic Parents

    -Crime, Violence, Mass Shootings and Schizophrenia

    -Medical Management of Schizophrenia

    -1st Break Psychosis

    -Long-acting Injectable Antipsychotics in Early Illness

    -Medication Adherence

    -Exercise, Lifestyle, Diet Optimization

    For more notes on this episode, links to articles, visit our website:

    psychiatrypodcast.com

    Join David on Instagram: dr.davidpuder

    Twitter: @DavidPuder

    Facebook: DrDavidPuder

    CV of Dr. Michael A. Cummings

    Assistant Producer: Arvy Wuysang

    Editor: Trent Jones